Patent · US Active

Compounds suitable for treatment of haemophilia

US9125890B2 · kind B2 · utility

0Cited by
7References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 12, 2013
Grant dateSep 8, 2015
Priority date
Expiry dateJun 12, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P7/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to Von Willebrand (VWF) compounds as well as compositions suitable for treatment of blood clotting diseases. The present invention also relates to pharmaceutical compositions, freeze-dried or liquid, comprising (i) a Factor VIII molecule and (ii) a VWF compound.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.